Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Thorac Oncol. 2014 Dec;9(12):1810–1815. doi: 10.1097/JTO.0000000000000363

Table 2.

Individual Patient Characteristics of the Stage IVb Patients who are Currently NED

Patient Age
(years)
Sex Pack
years
Race Histology
type
Masaoka
Stage
at
diagnosis
Treatment Areas of
metastasis
Recurrence Disease
free
survival
since
resection
1 36 F 12 Asian Squamous IVb Resection/XRT/neoadjuvant chemotherapy Lymph node (no visceral metastasis) No 6.8 years+
2 43 F 0.6 White Lympho-epithelioma-like carcinoma IVb Resection/XRT/neoadjuvant chemotherapy Lymph node (no visceral metastasis) No 3.4 years+
3 82 M 0 White Lympho-eptihelioma-like carcinoma IVb Resection/XRT/neoadjuvant chemotherapy Lymph node (no visceral metastasis) Yes: local recurrence to mediastinum. Pt treated with resection. 4.9 years+